The Topographical Relationship between Visual Field Loss and Peripapillary Retinal Nerve Fibre Layer Thinning Arising from Long-Term Exposure to Vigabatrin
- 54 Downloads
The antiepileptic drug vigabatrin is associated with characteristic visual field loss (VAVFL) and thinning of the peripapillary retinal nerve fibre layer (PPRNFL); however, the relationship is equivocal.
The aim of this study was to determine the function–structure relationship associated with long-term exposure to vigabatrin, thereby improving the risk/benefit analysis of the drug.
A cross-sectional observational design identified 40 adults who had received long-term vigabatrin for refractory seizures, who had no evidence of co-existing retino-geniculo-cortical visual pathway abnormality, and who had undergone a standardized protocol of perimetry and of optical coherence tomography (OCT) of the PPRNFL. Vigabatrin toxicity was defined as the presence of VAVFL. The function–structure relationship for the superior and inferior retinal quadrants was evaluated by two established models applicable to other optic neuropathies.
The function–structure relationship for each model was consistent with an optic neuropathy. PPRNFL thinning, expressed in micrometres, asymptoted at an equivalent visual field loss of worse than approximately − 10.0 dB, thereby preventing assessment of more substantial thinning. Transformation of the outcomes to retinal ganglion cell soma and axon estimates, respectively, resulted in a linear relationship.
Functional and structural abnormality is strongly related in individuals with vigabatrin toxicity and no evidence of visual pathway comorbidity, thereby implicating retinal ganglion cell dysfunction. OCT affords a limited measurement range compared with perimetry: severity cannot be directly assessed when the PPRNFL quadrant thickness is less than approximately 65 µm, depending on the tomographer. This limitation can be overcome by transformation of thickness to remaining axons, an outcome requiring input from perimetry.
Compliance with Ethical Standards
SA was supported by an unrestricted grant from the Ministry of Higher Education, Kingdom of Saudi Arabia. The latter had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation of the manuscript.
Conflicts of interest
John M. Wild, Saleh Aljarudi, Philip E.M. Smith and Carlo Knupp declare that they have no conflicts of interest.
All procedures performed in studies involving human participants were in accordance with ethical standards of the Local Research and Ethics Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study had approval from the Local Research and Ethics Committee. For this type of study, formal consent is not required.
- 11.European Medicines Agency. Opinion of the Committee for proprietary medicinal products pursuant to Article 12 of Council Directive 75/319/EEC as amended for vigabatrin. Annex 1. Scientific conclusions and grounds for amendment of the summaries of product characteristics presented by the EMEA. London: European Medicines Agency; 1999. http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Vigabatrin_31/WC500014088.pdf. Accessed 31 July 2018.
- 21.Clayton LM, Devile M Punte T de Haan GJ, Sander JW, Acheson JF et al. Patterns of peripapillary retinal nerve fiber layer thinning in vigabatrin-exposed individuals. Ophthalmology 2012;119(10):2152–60.Google Scholar
- 26.Harding GF, Wild JM, Robertson KA, Rietbrock S, Martinez C. Separating the retinal electrophysiologic effects of vigabatrin. Treatment versus field loss. Neurology. 2000;55(3):347–52.Google Scholar
- 27.Wright T, Kumarappah A, Stavropoulos A Reginald A, Buncic JR, Westall CA. Vigabatrin toxicity in infants is associated with retinal defect in adolescence. A prospective observational study. Retina 2017;37(5):858–66.Google Scholar
- 38.Hood DC. Relating nerve fiber layer thickness to behavioural sensitivity in patients with glaucoma. The application of a linear mode. J Opt Soc Am. 2007;24(5):1426–30.Google Scholar
- 39.Wheat JL, Rangaswamy NV, Harwerth RS. Correlating RNFL thickness by OCT with perimetric sensitivity in glaucoma patients. J Glaucoma. 2012;21(2):95–101.Google Scholar
- 41.Hood DC, Anderson S, Rouleau J, Wenick AS, Grover LK, Behrens MM, et al. Retinal nerve fiber layer structure versus visual field function in patients with ischemic optic neuropathy. A test of a linear model. Ophthalmology 2008;115(5):904–10.Google Scholar
- 48.Bengtsson B, Heijl A. False-negative responses in glaucoma perimetry: indicators of patient performance or test reliability? Invest Ophthalmol Vis Sci. 2000;41(8):2201–4.Google Scholar
- 49.Wood JM, Wild JM. Crews SJ. Serial examination of the normal visual field using Octopus automated projection perimetry. Evidence for a learning effect. Acta Ophthalmol (Copenh). 1987;65(3):326–33.Google Scholar
- 57.Watson GM, Keltner JL, Chin EK, Harvey D, Nguyen A, Park SS. Comparison of retinal nerve fiber layer and central macular thickness measurements among five different optical coherence tomography instruments in patients with multiple sclerosis and optic neuritis. J Neuroophthalmol. 2011;31(2):110–6.CrossRefGoogle Scholar